DCM
LXRX icon

Driehaus Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Driehaus Capital Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-39,922
Closed -$552K – 584
2016
Q4 		$552K Sell
39,922
-144,369
-78% -$2.32M 0.02% 407
2016
Q3 		$3.33M Buy
184,291
+109,291
+146% +$1.76M 0.11% 185
2016
Q2 		$1.08M Buy
+75,000
New +$1.02M 0.04% 334
2015
Q4 		– Sell
-35,175
Closed -$378K – 595
2015
Q3 		$378K Buy
+35,175
New +$384K 0.01% 454

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Driehaus Capital Management's LXRX Position: Q1 2017 in Review

Driehaus Capital Management sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2017, closing a stake of 39,922 shares — an estimated $552K sold.

Driehaus Capital Management first reported a position in LXRX in Q3 2015 and held it in 4 quarters. The position peaked at $3.33M in Q3 2016. 137 funds tracked by Wall St. Rank hold LXRX as of Q1 2017.

  • Driehaus Capital Management reported no remaining Lexicon Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Driehaus Capital Management sold 39,922 Lexicon Pharmaceuticals shares in Q1 2017, an estimated $552K.
  • Driehaus Capital Management first reported a position in Lexicon Pharmaceuticals in Q3 2015 and held it in 4 quarters.
  • Driehaus Capital Management's Lexicon Pharmaceuticals position peaked at $3.33M in Q3 2016.
  • 137 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2017.

Based on Driehaus Capital Management's 13F filing for Q1 2017, filed 16 May 2017.